Although pain is a predictable consequence of surgery, effective intraoperative nociceptive blockade through multimodal analgesia, including spinal analgesics, may attenuate central pain pathway sensitisation and lower pain intensity after major abdominal surgery 1 .
been shown to synergistically produce rapid and sustained analgesia 3 .
Our study was designed to evaluate the potential benefits of subarachnoid morphine alone, or in combination with bupivacaine and fentanyl, as part of a combined spinal-epidural analgesia (CSE) regimen in elective low anterior resection. Our hypothesis was that the combination of subarachnoid bupivacaine, fentanyl and morphine, in addition to improving analgesia in the immediate perioperative period, confers beneficial effects that extend beyond the agents' expected duration of action.
Postoperative pain at rest, with movement and with cough was the primary clinical outcome. The need for supplemental intraoperative intravenous (iv) fentanyl and epidural bupivacaine, time to first postoperative analgesia request, postoperative analgesic drug use, patient satisfaction and sideeffects were designated as secondary outcomes.
MATERiAlS AnD METHODS

Study design
This was a prospective, randomised, doubleblind clinical trial. The study protocol was approved by the institutional Review Board and written informed consent was obtained from all patients. Sixty patients scheduled for elective low anterior resection for malignant rectal tumour were enrolled. inclusion criteria were age over 20 years, American Society of Anesthesiologists physical status i to iii and patient acceptance of CSE for postoperative analgesia. Exclusion criteria were any contraindication to neuraxial blockade, allergy to any of the medications used for the study, chronic opioid or non-steroidal anti-inflammatory drug use, drug addiction, psychiatric disorders and spine problems. Preoperative patient preparation included, in addition to routine bowel preparation, patient education and familiarisation with the visual analogue scale (vAS) for quantifying pain. An independent investigator prepared and dispensed all study drugs, based on a computer-generated randomisation schedule. The same experienced anaesthesiologist (Gv) performed all neuraxial blocks. All patients and medical personnel involved in the study were blinded to group assignment. To enhance safety, a sealed envelope containing information about study group assignment and doses of medications administered accompanied the patient throughout the study, in case complications appeared. All operations were performed by the same surgeon with a vertical midline incision.
Patient preparation
Patients received premedication with midazolam 2.5 mg IV, fluid pre-load with Hartmann's solution 1 litre, and antibiotic prophylaxis with iv ceftriaxone 2 g and metronidazole 500 mg. Electrocardiogram, pulse oximetry and non-invasive blood pressure were monitored and oxygen was given via facemask at 6 l/min during neuraxial block placement. All neuraxial blocks were performed in the operating room with sterile technique, in the right lateral decubitus position, using a needle-through-needle technique at the l2-3 interspace with an Epistar ® needle (Medimex, Hamburg, Germany, 18 G Tuohy needle, 22 G epidural catheter, 25 G pencil-point spinal needle). Patients were awake during block placement. lignocaine 2% with epinephrine 1:200,000 3 ml total was given via the epidural catheter as a test dose to confirm appropriate catheter placement. The Epistar ® CSE needle has two channels, one for the epidural catheter and one for spinal needle advancement. This design allows the anaesthesiologist to first insert and check the epidural catheter, and then advance the spinal needle through a separate channel without damaging the epidural catheter.
Three minutes after the epidural test dose, once appropriate epidural catheter placement was confirmed, the spinal needle was advanced and the subarachnoid study solution was injected. Depending on group assignment, patients received one of three subarachnoid solutions (total volume injected was 1.5 ml in all groups):
MBF group: morphine 200 μg, fentanyl 25 μg and 1.
bupivacaine 2 mg (0.8 ml of 0.25% solution), MB group: morphine 200 μg, bupivacaine 2 mg 2.
(0.8 ml of 0.25% solution) and normal saline 0.5 ml, M group: morphine 200 μg and normal saline 3.
1.3 ml.
Intraoperative management
After the subarachnoid injection, bupivacaine 0.25% 10 ml was administered through the epidural catheter, and sensory blockade level was measured by pinprick at the midclavicular line approximately 20 minutes later. At a minimum, sensory blockade from T6 to l1 was required before inducing general anaesthesia. if the minimum sensory blockade was not reached, the protocol dictated an additional epidural bupivacaine 0.25% 5 ml injection, but this was not necessary in any patient. General anaesthesia was induced with iv midazolam 2 mg, fentanyl 100 μg, propofol 2 mg/kg and pancuronium 0.08 mg/kg. Anaesthesia was maintained with O 2 /air mixture (FiO 2 0.5) and sevoflurane at age-adjusted 1 MAC end-tidal. Muscle relaxation was maintained with pancuronium 0.01 mg/kg based on train-of-four ulnar nerve stimulation, until the fascia was closed. A second epidural bupivacaine 0.25% 10 ml bolus was administered before incision, followed by epidural bupivacaine 0.25% 5 ml bolus injection every one hour for the remainder of the procedure. When criteria for insufficient analgesia, i.e. hypertension (20% over basic values), tachycardia (heart rate >100 beats/min), lacrimation, flushing, sweating, swallowing and/or movement were met, additional epidural bupivacaine 0.25% 3 ml was given: then, if insufficient analgesia persisted after 10 more minutes, iv fentanyl 50 μg was added.
Ringer's lactate solution was given iv to replace intraoperative fluid maintenance requirements and 6% hetastarch (HES 130/0.4, Fresenius, Bad Hamburg, Germany) was infused as replacement for blood loss. When the systolic blood pressure fell below 90 mmHg despite adequate fluid infusion, ephedrine 5 mg was administered iv. Starting at the time the fascia was closed, an intermittent bolus of morphine 2 mg and bupivacaine 0.125% 13 ml was administered through the epidural catheter every eight hours. At the end of the procedure, residual neuromuscular blockade was reversed with neostigmine 2.5 mg and glycopyrrolate 0.5 mg. Patients who met extubation criteria (recovery from anaesthesia, spontaneous breathing, haemodynamic stability and normothermia) were extubated and transported to an observation unit, whereas patients requiring continuation of mechanical ventilation were transported to the intensive care unit.
Postoperative management
Pain was assessed with vAS (0=no pain, 100 mm =the worst pain imaginable) at rest, on movement from the supine to the sitting position and with cough. Tramadol 50 mg was administered slowly iv for vAS at rest >30 mm, on movement from the supine to the sitting position >40 mm or when a patient requested additional analgesia. Time to first analgesia request was defined as the time between application of the wound dressing at the end of surgery and the first analgesia request. The amount of additional iv tramadol given was recorded.
vAS and haemodynamic data were recorded at scheduled intervals (at 0 minutes, 30 minutes and 1, 2, 3, 4, 6, 12, 18, 24, 48 and 72 hours) starting at the end of surgery. When a patient was asleep at the time of a scheduled assessment, we did not wake him or her to obtain pain intensity scores. The situation where a patient was asleep when vAS pain intensity values would be obtained occurred only in 1.1% of scheduled measurements during the study. Pain intensity scores on these occasions were recorded and treated as 'missing data' during statistical analysis.
Epidural analgesia was maintained for 72 hours postoperatively and patients were assessed for epidural catheter technical failure (catheter kinking, dislodgment or migration) after each analgesia request. in cases where the epidural catheter became non-functional before the 72 hour limit, analgesia was provided with tramadol 100 mg iv every six hours. These cases were not excluded from the study; instead, data were recorded for the time period before the catheter became non-functional.
Postoperative fluid administration was based on hospital protocol (1500 ml of Ringer lactate and 5% dextrose). Motor block was assessed with the Bromage scale 4 and sedation with the Ramsay scale 5 . Extubation time was recorded as 1) extubation in the operating room within 10 minutes of wound closure or 2) extubation in the recovery room more than 10 minutes after wound closure. nausea, vomiting, pruritus (none, mild, moderate or severe), respiratory depression (respiratory rate <8 breaths per minute), hypotension (systolic blood pressure <90 mmHg) and other postoperative complications were recorded. All patients were assessed on the morning of the first postoperative day by a member of the study team and were asked to walk 5 m with assistance if there were no motor deficits or orthostatic hypotension. in the postoperative period all patients received low molecular weight heparin (subcutaneous enoxaparin 20 mg once daily), in accordance with recently published guidelines 6 . Complications related to neuraxial anaesthesia (back pain, radiculopathy, meningitis, spinal abscess or haematoma, post dural puncture headache) were recorded. Patient satisfaction with CSE was rated on a 5 point scale (i.e. very dissatisfied=1, dissatisfied=2, neutral=3, satisfied=4 or very satisfied=5) and recorded on postoperative day four.
Statistical analysis
Before the study started, power analysis indicated that the appropriate sample size would be 18 patients per group, based on the following assumptions: between-group differences in the mean vAS on movement from the supine to the sitting position 20 mm, standard deviation (SD) 17 mm, power 70% and alpha 0.05. These assumptions were based on an earlier study by liu et al 7 . However, we decided to include 20 patients in each group, to allow for the possibility of patient attrition and missing data.
Data distribution was evaluated with the kolmogorov-Smirnov and Shapiro-Wilk tests, to ensure appropriate use of parametric and non-parametric tests. Depending on data distribution, data are presented as mean ± SD or as median (range). A P <0.05 was considered significant for all statistical analysis. Demographic data were analysed with analysis of variance (AnOvA), Pearson's chisquare test or the least likelihood chi-square test as appropriate. intraoperative data were analysed with AnOvA, followed by Bonferroni post-hoc test. vAS data did not meet criteria for parametric testing and were treated as ordinal data. The area under vAStime curve for pain during the postoperative 72 hours was analysed with the kruskal-Wallis test, whereas the area under the haemodynamic variables (systolic and diastolic blood pressure, heart rate) vs time curve for intraoperative and postoperative values were analysed with one-way AnOvA. For nominal data, the Pearson chi-square or least likelihood chisquare tests were used. However, as patient number per group was not adequate for chi-square testing, patient satisfaction data are presented without analysis. Statistical analysis was performed with the SPSS, version 15.0 for Windows statistical software package (SPSS inc., Chicago, il, USA).
RESUlTS
Sixty patients enrolled in one year. Of those, two patients (one in the MB group, one in the M group) were later excluded because the surgical procedure changed from low anterior resection to exploratory laparotomy only. All patient groups had similar characteristics ( Table 1) .
The subarachnoid and epidural spaces were successfully identified in all patients. There were no differences between groups with respect to anaesthesia duration and colloid infusion ( Table 2) . intraoperatively, the MBF group required significantly lower epidural bupivacaine doses compared to the MB (P=0.011) and M (P=0.003) groups. The amount of additional iv fentanyl was significantly lower in the MBF compared to the MB (P=0.019) and M (P=0.01) groups ( Table 2 ). The percentage of patients extubated immediately after surgery did not differ between groups (Table 2) .
Good pain relief was maintained in all groups throughout the 72 hour postoperative period ( Figure 1 ). The area under the vAS-time curve scores for pain at rest, with movement and with cough was not significantly different between groups (Table 3) . (P=0.009 on post-hoc testing, Table 4 ). Patients in the MB group received a lower amount of tramadol on postoperative day two compared to patients in the MBF group (P=0.017, Figure 2 ). However, pooled three-day postoperative tramadol use and satisfaction scores did not differ significantly between groups ( Table 4 ). The mean area under the heart rate and systolic and diastolic blood pressure time curves did not differ between groups in the intraoperative and postoperative period ( Table 5) .
Effective analgesia duration was significantly longer in the MBF compared to the M group
Mild nausea was more frequent at 24 hours in the MB (3/17, 17.6%, P=0.026) and M (4/18, 22.2%, P=0.039) groups compared to the MBF group (0/20) ( Table 6 ). The frequency of vomiting, hypotension and sedation did not differ significantly between groups ( Table 6 ), but one patient in the MB group had mild pruritus at 48 and 72 hours. All episodes of hypotension resolved with infusion of Ringer's lactate 500 ml. All patients ambulated the morning after surgery. There was no case of respiratory depression and no morbidity related to neuraxial blockade in any group. Postoperative morbidity and mortality did not differ between groups. One patient died in group M due to massive pulmonary embolism on the fourth postoperative day.
DiSCUSSiOn
This study was designed to evaluate the potential advantages of combining subarachnoid bupivacaine and/or fentanyl with subarachnoid morphine as part of CSE in open colorectal surgery. The combination of subarachnoid morphine, bupivacaine and fentanyl has been shown to provide useful analgesia in other clinical settings [8] [9] [10] . in this study we sought to investigate whether a similar benefit could be demonstrated in open colorectal surgery with midline laparotomy incisions.
The choice of study medications was based on the concept of anti-nociceptive synergy: subarachnoid fentanyl provides rapid (within 5 to 10 minutes) analgesia onset, improves surgical blockade quality 11 and enhances the effect of small subarachnoid bupivacaine doses 12 , whereas subarachnoid morphine provides prolonged (lasting up to 24 hours) analgesia 13 . Furthermore, subarachnoid bupivacaine potentiates epidural bupivacaine 14 and the antinociceptive subarachnoid morphine effect 15 . Provision of adequate postoperative analgesia at rest, with movement and with cough was the main study end-point. Reduction of intraoperative analgesia requirements, time to first postoperative analgesia request, postoperative analgesic drug use, patient satisfaction and analgesic medication-related side-effects were designated as secondary study endpoints.
Previous studies investigating CSE in colorectal surgery have used different methods and produced different results 16, 17 . Scott et al 16 combined continuous thoracic (T8-11) epidural bupivacaine/diamorphine analgesia with lumbar (l2-3) subarachnoid bupivacaine (0.5% 6 ml) anaesthesia in colorectal surgery and found that, compared to thoracic epidural analgesia alone, CSE did not confer any additional benefit in terms of analgesia, pulmonary function or neuro-endocrine response in the first 24 postoperative hours. in contrast, Dahl et al 17 used a double-catheter technique. They administered lumbar (l3-4) subarachnoid lignocaine 5% at incremental 25 mg doses to obtain T4 to S5 level, combined with thoracic epidural bupivacaine 0.75% 7 ml and morphine 2 mg, and showed that the combination of lumbar subarachnoid anaesthesia with thoracic epidural analgesia is very effective, but there was no control group.
Compared to these studies, our study has several advantages. First, the amount of local anaesthetic used for the subarachnoid component of CSE was smaller. Second, the CSE needle was inserted in the lumbar area, below the level of spinal cord termination, thereby minimising potential harm to nerve structures 18 . Third, the Epistar ® CSE kit used in the study allows epidural catheter insertion before the subarachnoid injection, thereby allowing detection of catheter problems before they are masked by the subarachnoid local anaesthetic injection 19 .
Our results suggest that the main benefit of adding fentanyl and bupivacaine to subarachnoid morphine were reduced intraoperative iv fentanyl and epidural bupivacaine use in the MBF group and delayed first analgesia request in the MBF group compared to the M group. However, vAS pain scores did not differ significantly between groups, possibly because subarachnoid morphine effectively suppressed pain in all groups. Group MB required significantly less tramadol on postoperative day two compared to the MBF group. As all patients had access to adequate pain relief and pain scores did not differ significantly between groups, one could argue that the postoperative analgesia requirement effectively becomes an important outcome, and can be a reasonable way to detect differences in quality of analgesia between groups. Although subarachnoid morphine and fentanyl dose was based on literature data 13, 20 , we can argue that larger doses were needed to provide superior analgesia in the MBF group.
The incidence of side-effects associated with neuraxial opioids 21 including nausea, vomiting and pruritus was low and there was no case of respiratory depression. Our study did not have adequate power to assess the impact, if any, of CSE on morbidity and mortality. However, the death of one patient in the M group on day four from pulmonary embolism 
